| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00086 | 1 |
| mRNA | BRD-K41334119 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.00085 | 1 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.0008 | 1 |